4basebio PLC (FRA:88Q)
13.00
-0.10 (-0.76%)
At close: May 13, 2025, 10:00 PM CET
4basebio Revenue
4basebio had revenue of 328.00K GBP in the half year ending June 30, 2024, with 115.79% growth. This brings the company's revenue in the last twelve months to 596.00K, up 68.36% year-over-year. In the year 2023, 4basebio had annual revenue of 506.00K with 88.81% growth.
Revenue (ttm)
596.00K GBP
Revenue Growth
+68.36%
P/S Ratio
243.45
Revenue / Employee
7.10K GBP
Employees
84
Market Cap
171.14M EUR
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 506.00K | 238.00K | 88.81% |
Dec 31, 2022 | 268.00K | -70.00K | -20.71% |
Dec 31, 2021 | 338.00K | -124.00K | -26.84% |
Dec 31, 2020 | 462.00K | -346.00K | -42.82% |
Dec 31, 2019 | 808.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Siemens Healthineers AG | 23.14B |